Transmembrane Serine Protease TMPRSS11B promotes an acidified tumor microenvironment and immune suppression in lung squamous cell carcinoma
Sunil, H. S.; Clemenceau, J.; Barnfather, I.; Nakkireddy, S. R.; Grichuk, A.; Izzo, L. T.; Evers, B. M.; Thomas, L.; Subramaniyan, I.; Li, L.; Putnam, W. T.; Zhu, J.; Updegraff, B.; Minna, J. D.; DeBerardinis, R. J.; Gao, J.; Hwang, T. H.; Oliver, T. G.; O'Donnell, K. A.
Show abstract
Lung cancer is the leading cause of cancer-related deaths worldwide. Existing therapeutic options have limited efficacy, particularly for lung squamous cell carcinoma (LUSC), underscoring the critical need for the identification of new therapeutic targets. We previously demonstrated that the Transmembrane Serine Protease TMPRSS11B promotes transformation of human bronchial epithelial cells and enhances lactate export from LUSC cells. To determine the impact of TMPRSS11B activity on the host immune system and the tumor microenvironment (TME), we evaluated the effect of Tmprss11b depletion in a syngeneic mouse model. Tmprss11b depletion significantly reduced tumor burden in immunocompetent mice and triggered an infiltration of immune cells. RNA FISH analysis and spatial transcriptomics in the autochthonous Rosa26-Sox2-Ires-GfpLSL/LSL; Nkx2-1fl/fl; Lkb1fl/fl (SNL) model revealed an enrichment of Tmprss11b expression in LUSC tumors, specifically in Krt13+ hillock-like cells. Ultra-pH sensitive nanoparticle imaging and metabolite analysis identified regions of acidification, elevated lactate, and enrichment of M2-like macrophages in LUSC tumors. These results demonstrate that TMPRSS11B promotes an acidified and immunosuppressive TME and nominate this enzyme as a therapeutic target in LUSC.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers 96%
- A single cell atlas reveals distinct immune landscapes in transplant and primary tumors that determine response or resistance to immunotherapy 96%
- Glioma-neuronal circuit remodeling induces regional immunosuppression 96%
Similar papers in this journal
Similar papers in this journal
- Identifying a gene signature of metastatic potential by linking pre-metastatic state to ultimate metastatic fate 96%
- Epigenomic signatures as circulating and predictive biomarkers in sarcomatoid renal cell carcinoma 95%
- A multiplexed in vivo approach to identify driver genes in small cell lung cancer 95%
Similar papers in this journal
- Regulation of lung cancer initiation and progression by the stem cell determinant Musashi 97%
- Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer 95%
- Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer 95%
Similar papers in this journal
- Radioproteomics stratifies molecular response to antifibrotic treatment in pulmonary fibrosis 95%
- Ddr1-Induced Neutrophil Extracellular Traps Drive Pancreatic Cancer Metastasis 95%
- AI-assisted Discovery of an Ethnicity-influenced Driver of Cell Transformation in Esophageal and Gastroesophageal Junction Adenocarcinomas 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.